Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
6
4
1
0
MERRIMACK PHARMACEUTICALS INC
Share · US5903282094 · MACK · A2DW3Q (XNMS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MERRIMACK PHARMACEUTICALS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 65,34 %
Shares Float 9,66 M
Shares Outstanding 14,79 M
Company Profile for MERRIMACK PHARMACEUTICALS INC Share
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Company Data
Name MERRIMACK PHARMACEUTICALS INC
Company Merrimack Pharmaceuticals, Inc.
Symbol MACK
Website
https://www.merrimack.com
Primary Exchange 
NASDAQ/NMS (GLOBAL MARKET)
NASDAQ/NMS (GLOBAL MARKET)
WKN A2DW3Q
ISIN US5903282094
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gary L. Crocker
Market Capitalization 224 Mio
Country United States of America
Currency USD
Employees -
Address One Broadway, 02142 Cambridge
IPO Date 2012-03-29
Dividends from 'MERRIMACK PHARMACEUTICALS INC'
| Ex-Date | Dividend per Share |
|---|---|
| 20.05.2024 | 15,10 USD |
| 13.12.2019 | 0,50 USD |
| 06.09.2019 | 1,50 USD |
| 30.05.2017 | 1,06 USD |
Stock Splits
| Date | Split |
|---|---|
| 06.09.2019 | 1271:1000 |
| 06.09.2017 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | MACK |
More Shares
Investors who hold MERRIMACK PHARMACEUTICALS INC also have the following shares in their portfolio:
